Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
DN.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BE.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BE.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BE.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.1.1.15NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.1.1.15NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.1.1.15NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.7.16NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.7.16NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.7.16NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.3.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.3.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.3.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CQ.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CQ.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CQ.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EC.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EC.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EC.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.52NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.2.52NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.52NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBQNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBQNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBQNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.6.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.6.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.6.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CR.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CR.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CR.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BV.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BV.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BV.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GA.4.1.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GA.4.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GA.4.1.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GS.7.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GS.7.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GS.7.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XWNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XWNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XWNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.1.10NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.1.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.1.10NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KG.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used